Equities

Abbott India Ltd

ABBOTINDIA:NSI

Abbott India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)27,718.50
  • Today's Change598.50 / 2.21%
  • Shares traded6.11k
  • 1 Year change+16.02%
  • Beta0.1319
Data delayed at least 15 minutes, as of Nov 22 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments21,19719,24327,375
Total Receivables, Net4,6314,1733,946
Total Inventory6,3646,6347,022
Prepaid expenses906770
Other current assets, total176134117
Total current assets32,45830,25138,530
Property, plant & equipment, net2,2842,3312,630
Goodwill, net------
Intangibles, net677586
Long term investments16,18411,890161
Note receivable - long term783839664
Other long term assets------
Total assets51,93545,55542,241
LIABILITIES
Accounts payable10,0278,9208,895
Accrued expenses478538532
Notes payable/short-term debt000
Current portion long-term debt/capital leases465457430
Other current liabilities, total2,4582,1462,176
Total current liabilities13,42712,06012,032
Total long term debt3686751,087
Total debt8321,1321,517
Deferred income tax------
Minority interest------
Other liabilities, total1,151935924
Total liabilities14,94613,67014,043
SHAREHOLDERS EQUITY
Common stock213213213
Additional paid-in capital------
Retained earnings (accumulated deficit)36,40731,28027,612
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(32)(32)(68)
Total equity36,98931,88528,198
Total liabilities & shareholders' equity51,93545,55542,241
Total common shares outstanding212121
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.